Sun Pharma amongst 2026 S&P Dow Jones Best-in-Class World Index

Sun Pharmaceutical Industries Ltd. has been included in the 2026 S&P Dow Jones Best-in-Class World Index, a globally respected benchmark that recognizes companies demonstrating strong leadership in sustainable performance.

The Dow Jones Best-in-Class Indices methodology identifies companies that lead their industries in addressing material sustainability issues and set global benchmarks for corporate sustainability performance. Based on the S&P Global Broad Market Index, nearly 2,500 of the world's largest companies were identified by S&P Global. Among them, around 317 companies worldwide qualified, including 25 from India, for inclusion in the 2026 DJBIC Index, making this recognition especially significant for us.

Kirti Ganorkar, Managing Director, Sun Pharma said, "This recognition is a testament to our continued commitment to responsible business practices and sustainable growth. At Sun Pharma, sustainability is embedded in the way we think, operate, and create value. It guides our purpose, shapes our actions, and remains central to our long-term strategy. Together with our people, we will continue driving meaningful impact through responsible innovation, climate-conscious operations, strong governance, and inclusive growth, while building a more sustainable future for generations to come."

About Sun Pharmaceutical Industries Limited (CIN - L24230GJ1993PLC019050):

Sun Pharma is the world's leading specialty generics company with a presence in Innovative Medicines, Generics and Consumer Healthcare products. It is the largest pharmaceutical company in India and is a leading generic company in the US as well as Global Emerging Markets. Sun's high growth Global Innovative Medicines portfolio spans innovative products in dermatology, ophthalmology, and onco-dermatology and accounts for about 22% of company sales. The company's vertically integrated operations deliver high-quality medicines, trusted by physicians and consumers in over 100 countries. Its manufacturing facilities are spread across five continents. Sun Pharma is proud of its multi-cultural workforce drawn from over 50 nations.